Compare

Kimberly-Clark vs Kenvue

MonkScore ranges and fundamentals, side by side

Key facts

Kimberly-Clark and Kenvue: key facts

  • In fiscal 2025, Kimberly-Clark Corporation reported revenue of $17.2B and net income of $2.0B.
  • In fiscal 2025, Kenvue Inc. reported revenue of $15.1B and net income of $1.5B.
  • Kimberly-Clark Corporation's revenue fell 3.0% a year from fiscal 2021 to fiscal 2025.
  • Kenvue Inc.'s revenue was about flat from fiscal 2021 to fiscal 2025.
  • Kimberly-Clark Corporation's free cash flow was positive in 5 of the 5 fiscal years from 2021 to 2025.
  • Kenvue Inc.'s free cash flow was positive in 5 of the 5 fiscal years from 2021 to 2025.
  • In the twelve months to 30 June 2026, Kimberly-Clark Corporation reported revenue of $16.6B and net income of $2.0B.
  • In the twelve months to 27 September 2026, Kenvue Inc. reported revenue of $15.5B and net income of $1.7B.

Side by side

Kimberly-Clark and Kenvue, side by side

Each figure is in the company's reporting currency, with its fiscal year or the date of its last report.

FigureKimberly-Clark CorporationNASDAQ:KMBKenvue Inc.NYSE:KVUE
MonkScore
MonkScore range60–70as of October 202650–60as of October 2026
Sector rank139 of 428 in Consumer Defensive174 of 428 in Consumer Defensive
How this score is madeDisclaimer
Profile
SectorConsumer DefensiveConsumer Defensive
IndustryHousehold & Personal ProductsHousehold & Personal Products
Latest fiscal year
Revenue$17.2BFY 2025$15.1BFY 2025
Net income$2.0BFY 2025$1.5BFY 2025
Free cash flow$1.6BFY 2025$1.7BFY 2025
Operating cash flow$2.8BFY 2025$2.2BFY 2025
Total debt$7.3BFY 2025$8.5BFY 2025
Cash$688.0MFY 2025$1.1BFY 2025
Last 12 months
Revenue$16.6Bto 30 June 2026$15.5Bto 27 September 2026
Net income$2.0Bto 30 June 2026$1.7Bto 27 September 2026
Free cash flow$2.6Bto 30 June 2026$2.5Bto 27 September 2026
Operating cash flow$3.3Bto 30 June 2026$2.7Bto 27 September 2026
Total debt$6.5Bto 30 June 2026$8.3Bto 27 September 2026
Cash$956.0Mto 30 June 2026$1.0Bto 27 September 2026

MonkStreet provides research, not investment advice.